PACB
Pacific Biosciences of California, Inc.
Medical Devices · Healthcare · United States
2.61
close · 2026-10-30
value
12
cheaper than peers12
quality
2
stronger fundamentals2
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| EV to EBITDA | 6.67× | 93 |
| cash flow yield, latest year | -14.7% | 27 |
| earnings yield, 2 years ago | -46.4% | 26 |
| price to sales | 5.08× | 26 |
| earnings yield, 3 years ago | -53.7% | 23 |
| cash flow yield, 3 years ago | -34.6% | 21 |
| cash flow yield, 1 year ago | -26.2% | 20 |
| earnings yield, 1 year ago | -60.7% | 18 |
| cash flow yield, 2 years ago | -33.1% | 16 |
| earnings yield, latest year | -69.9% | 12 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | -1.9% | 19 |
| operating margin | -114.4% | 13 |
| return on equity | -929.3% | 2 |
3 of 4 measures available
Facts
| market cap | $810M |
| free cash flow | $291.6M |
| employees | 485 |
| first trade | 2010-10-27 |
| next earnings | 2026-11-04 |
| fundamentals updated | 2026-08-28 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -1.82 | -1.58 | -1.21 | -1.40 |
| free cash flow | -$118.9M | -$212.2M | -$268.0M | -$280.1M |
| net income | -$546.4M | -$309.9M | -$306.7M | -$314.2M |
| revenue | $160.0M | $154.0M | $200.5M | $128.3M |
| unusual items | $3.7M | -$29.2M | -$26.1M | -$2.4M |